Can knee cartilage reveal why osteoarthritis worsens?

NCT ID NCT07796607

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This study examines cartilage from people undergoing total knee replacement for osteoarthritis. Researchers will use a microscope to look at cell health, mitochondria, and autophagosomes, which are parts of cells involved in cleaning up damage. The goal is to better understand how cartilage breaks down and to identify possible targets for future treatments. Participants provide a small piece of cartilage during surgery and have follow-up visits one and two weeks later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this research succeeds, it could point toward new treatments that slow or stop cartilage breakdown in osteoarthritis.
What could go wrong
This is a small, early study that only looks at tissue samples. It may not lead directly to new treatments, and findings may not apply to all people with osteoarthritis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study enrolled 15 OA patients and 15 normal controls at Kunming Hospital of Traditional Chinese Medicine. All provided informed consent; basic and disease data were collected. Cartilage specimens were obtained intraoperatively by orthopedic surgeons. OA group: total knee arthroplasty patients. Normal control group: OA-free subjects from two sources: (1) femoral head replacement (Garden I/II) or knee arthroscopy for meniscal/ligament injury, and (2) traumatic lower-limb amputation. In source 1, cartilage was taken from the operated joint (hip/knee); in source 2, from the intact joint of the amputated limb. All control cartilage was confirmed Outerbridge grade 0 intraoperatively.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Osteoarthritis group: 1. Meets the American College of Rheumatology (ACR) diagnostic criteria for osteoarthritis: ① Persistent knee pain for ≥1 month; ② X-ray shows osteophytes at the knee joint margin; ③ Age ≥50 years; ④ Morning stiffness \<30 minutes; ⑤ Knee joint friction sounds. (Diagnosis requires item ① plus any two of items ②-⑤). 2. Radiographic Kellgren-Lawrence (K-L) grade ≥2; 3. Complete the entire treatment course without interruption or modification of the treatment plan during the process; 4. Complete the full-process assessment and follow-up; 5. The image and medical record materials are complete. Normal control group: Normal Control Group (subjects must meet criteria for one of the following two sources): (1) Source A - Non-arthritic surgery patients: 1)No history of knee osteoarthritis, rheumatoid arthritis, gouty arthritis, infectious arthritis, or other joint diseases 2)Undergoing surgery for one of the following indications: 1. Femoral neck fracture (Garden type I/II) treated with artificial femoral head replacement 2. Simple meniscus injury or ligament injury requiring knee arthroscopy 3)Preoperative X-ray of the joint from which cartilage will be collected shows normal joint space, K-L grade 0, and no osteophytes, subchondral sclerosis, or cystic change (hip joint for femoral head replacement; knee joint for arthroscopy) 3)Intraoperative macroscopic observation or specimen evaluation confirms smooth cartilage surface with no softening, fissure, or fibrosis (Outerbridge grade 0) 4)Complete imaging and medical records available Source B - Traumatic amputees: 1. No history of any joint disease (knee osteoarthritis, rheumatoid arthritis, gouty, infectious arthritis, etc.) 2. Undergoing amputation of a lower limb purely for traumatic reasons, with no pre-existing joint pathology in the limb to be amputated 3. Preoperative X-ray of the target joint (typically knee or hip) shows K-L grade 0 and no signs of osteoarthritis 4. Intraoperative macroscopic evaluation of the articular cartilage from the amputated limb confirms Outerbridge grade 0 (smooth, intact surface) 5. Complete imaging and medical records available Both sources: Signed informed consent for voluntary participation Exclusion Criteria: ① Combined with other types of joint diseases, autoimmune diseases or bone metabolic diseases; ② Has a history of drug abuse; ③ Those who have not signed the informed consent form; ④ Suffering from mental illness and unable to cooperate with research; ⑤ Other personnel who are not suitable to participate in the research.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osteoarthritis (OA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Yunnan University of Chinese Medicine

    Kunming, Yunnan, 650500, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.